246 related articles for article (PubMed ID: 16311411)
1. Pituitary tumors: prognostic indicators.
Saeger W
Endocrine; 2005 Oct; 28(1):57-66. PubMed ID: 16311411
[TBL] [Abstract][Full Text] [Related]
2. Invasive pituitary adenomas: significance of proliferation parameters.
Amar AP; Hinton DR; Krieger MD; Weiss MH
Pituitary; 1999 Aug; 2(2):117-22. PubMed ID: 11081161
[TBL] [Abstract][Full Text] [Related]
3. Genetic basis of pituitary adenoma invasiveness: a review.
Suhardja A; Kovacs K; Rutka J
J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
[TBL] [Abstract][Full Text] [Related]
4. Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.
de Aguiar PH; Aires R; Laws ER; Isolan GR; Logullo A; Patil C; Katznelson L
Neurol Res; 2010 Dec; 32(10):1060-71. PubMed ID: 20483025
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
6. Current biomarkers of invasive sporadic pituitary adenomas.
Zheng X; Li S; Zhang W; Zang Z; Hu J; Yang H
Ann Endocrinol (Paris); 2016 Dec; 77(6):658-667. PubMed ID: 27659267
[TBL] [Abstract][Full Text] [Related]
7. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic correlates of giant pituitary adenomas.
Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
14. Proliferation markers and cell cycle inhibitors in pituitary adenomas.
Saeger W
Front Horm Res; 2004; 32():110-26. PubMed ID: 15281342
[TBL] [Abstract][Full Text] [Related]
15. Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis.
Hui P; Xu X; Xu L; Hui G; Wu S; Lan Q
Int J Clin Exp Pathol; 2015; 8(4):3556-67. PubMed ID: 26097538
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.
Gomez-Hernandez K; Ezzat S; Asa SL; Mete Ö
Turk Patoloji Derg; 2015; 31 Suppl 1():4-17. PubMed ID: 26177314
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of pituitary adenomas.
Lloyd RV
J Neurooncol; 2001 Sep; 54(2):111-9. PubMed ID: 11761428
[TBL] [Abstract][Full Text] [Related]
18. Non-functioning pituitary adenomas: growth and aggressiveness.
Øystese KA; Evang JA; Bollerslev J
Endocrine; 2016 Jul; 53(1):28-34. PubMed ID: 27066792
[TBL] [Abstract][Full Text] [Related]
19. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
